Trial Profile
Study of the effects of current drug treatments on levels of certain brain chemicals in Alzheimer's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jan 2010
Price :
$35
*
At a glance
- Drugs Rivastigmine (Primary)
- Indications Alzheimer's disease
- Focus Biomarker; Pharmacodynamics
- 02 Jul 2007 Status changed from recruiting to completed
- 15 Oct 2005 New trial record.